Nextage Therapeutics Ltd (TLV:NXTG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
0.6770
0.00 (0.00%)
At close: May 4, 2026

Nextage Therapeutics Cash Flow Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
2.84-3.28-3.88-5.59-7.73-15.97
Depreciation & Amortization
-0.040.10.130.060.190.1
Asset Writedown & Restructuring Costs
----1.23-
Loss (Gain) on Equity Investments
-0.44---0.020.07-
Stock-Based Compensation
000.090.472.02-
Other Operating Activities
0.56-0.18-0.32-0.38-0.6912.9
Change in Accounts Receivable
-0.550.21-0.240.02-0.030.01
Change in Accounts Payable
-0.470.12-0.01-0.310.24-0.98
Change in Other Net Operating Assets
0.992.241.97-0.250.73-2.38
Operating Cash Flow
-2.32-0.8-2.26-6.01-3.97-6.31
Capital Expenditures
----0--0.01
Cash Acquisitions
0.3----7.98
Investment in Securities
-0.03-----0.02
Other Investing Activities
-0.18-0.1800.02-0.06-
Investing Cash Flow
0.09-0.1800.02-0.067.95
Short-Term Debt Issued
--0.12---
Long-Term Debt Issued
-0.030.50.210.95-
Total Debt Issued
-0.310.030.620.210.95-
Short-Term Debt Repaid
--0.1-0.21-0.2-0.19-0.06
Long-Term Debt Repaid
--0.03-0.09-0.03-0.07-1.8
Total Debt Repaid
-1.23-0.13-0.3-0.23-0.26-1.86
Net Debt Issued (Repaid)
-1.54-0.10.32-0.020.69-1.86
Issuance of Common Stock
3.330.641.163.440.182.26
Other Financing Activities
0.11---0.034.6-
Financing Cash Flow
1.90.541.483.395.470.4
Foreign Exchange Rate Adjustments
0.030.030.130.39-0.2-
Net Cash Flow
-0.3-0.4-0.65-2.211.232.03
Free Cash Flow
-2.32-0.8-2.26-6.02-3.97-6.32
Free Cash Flow Margin
-954.73%-192.49%-258.22%--4367.03%-3309.42%
Free Cash Flow Per Share
-0.13-0.02-0.08-0.22-0.15-0.55
Cash Interest Paid
--0.030.030.040.09
Levered Free Cash Flow
5.990.5-0.56---
Unlevered Free Cash Flow
6.010.52-0.53---
Change in Working Capital
-0.022.571.72-0.540.94-3.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.